Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

• Authors: VERMA Subodh; LUDKA Ondřej; DHINGRA Nitish K; BUTLER Javed; ANKER Stefan D; FERREIRA Joao Pedro; FILIPPATOS Gerasimos; JANUZZI James L; LAM Carolyn S P; SATTAR Naveed; PEIL Barbara; NORDABY Matias; BRUECKMANN Martina; POCOCK Stuart J; ZANNAD Faiez; PACKER Milton
• Year of publication: 2022
• Type: Article in Periodical
• Magazine / Source: LANCET DIABETES & ENDOCRINOLOGY
• MU Faculty or unit: Faculty of Medicine
• Doi: http://dx.doi.org/10.1016/S2213-8587(21)00292-8